Study Evaluating Sirolimus in the Treatment of Kidney Transplant

NCT00282217 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Failure
Kidney Diseases

Interventions

DRUG: Sirolimus

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer